Literature DB >> 8363117

Blood pressure during the first minutes of focal cerebral ischemia.

J Broderick1, T Brott, W Barsan, E C Haley, D Levy, J Marler, G Sheppard, C Blum.   

Abstract

STUDY
OBJECTIVE: To determine whether blood pressure declines spontaneously during the first minutes and hours of focal cerebral ischemia.
DESIGN: Multiple blood pressure measurements as part of an urgent stroke therapy trial (treatment within 90 minutes of stroke onset).
SETTING: Thirteen hospitals in three metropolitan communities. PARTICIPANTS: Sixty-nine patients (mean age, 65 +/- 9 years) with acute ischemic stroke who were participants in a phase I urgent stroke therapy trial of recombinant tissue plasminogen activator. MAIN OUTCOME MEASURE: Blood pressures recorded at the scene of stroke by life-squad personnel, in the emergency department, and in the ICU.
RESULTS: The mean time from stroke onset to the time of first blood pressure measurement was 19 +/- 13 minutes. Twenty-four of the 69 patients in the urgent stroke therapy trial had an initial systolic blood pressure of at least 160 mm Hg. Of these, 23 had a significant decline in systolic and diastolic blood pressure during the first 90 minutes after the onset of stroke (mean change in systolic pressure, -29 +/- 22 mm Hg, P < .001; mean change in diastolic pressure, -10 +/- 14 mm Hg, P < .01). No patients received antihypertensive therapy during the time in which the decline in blood pressure was noted.
CONCLUSION: Mildly or moderately elevated blood pressure frequently declines spontaneously during the first minutes and hours of focal cerebral ischemia and generally does not require urgent pharmacologic treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8363117     DOI: 10.1016/s0196-0644(05)81993-6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  14 in total

1.  [Recommendations of the European Stroke Initiative (EUSI) for treatment of ischemic stroke--update 2003. I. organization and acute therapy].

Authors:  Sonja Külkens; Peter Arthur Ringleb; Werner Hacke
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

2.  Cardiac output in patients with acute stroke.

Authors:  J Treib; A Haass; I Krammer; M Stoll; M T Grauer; K Schimrigk
Journal:  J Neurol       Date:  1996-08       Impact factor: 4.849

Review 3.  [Acute cerebral circulation problems].

Authors:  P D Schellinger; R Kollmar; U K Meyding-Lamadé; J B Fiebach; W Hacke
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

4.  Prehospital systolic blood pressure is higher in acute stroke compared with stroke mimics.

Authors:  Laura C Gioia; Rahel T Zewude; Mahesh P Kate; Kim Liss; Brian H Rowe; Brian Buck; Thomas Jeerakathil; Ken Butcher
Journal:  Neurology       Date:  2016-05-18       Impact factor: 9.910

5.  Hypoperfusion and Its Augmentation in Patients with Brain Ischemia.

Authors:  Robert J. Wityk; Lucas Restrepo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

6.  Management of Acute Hypertensive Response in Patients With Ischemic Stroke.

Authors:  Ahmad AlSibai; Adnan I Qureshi
Journal:  Neurohospitalist       Date:  2016-04-21

7.  [Sequelae of hypertension on end-organs of the brain].

Authors:  H C Diener; Th Philipp; J Schrader
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

Review 8.  Management of hypertension in the setting of acute ischemic stroke.

Authors:  Laura Heitsch; Edward C Jauch
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

9.  Predicting ischaemic stroke subtype from presenting systolic blood pressure: the BASIC Project.

Authors:  W J Meurer; B N Sánchez; M A Smith; L D Lisabeth; J J Majersik; D L Brown; K Uchino; F P Bonikowski; J E Mendizabal; D B Zahuranec; L B Morgenstern
Journal:  J Intern Med       Date:  2008-10-25       Impact factor: 8.989

10.  Angiotensin-converting enzyme inhibitors will help in improving stroke outcome if given immediately after stroke.

Authors:  M V Padma
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.